EMEA-001544-PIP01-13
Key facts
| Active substance |
Captopril
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0206/2014
|
| PIP number |
EMEA-001544-PIP01-13
|
| Pharmaceutical form(s) |
Age-appropriate oral liquid dosage form
|
| Condition(s) / indication(s) |
Treatment of heart failure
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Proveca Pharma Limited
E-mail: info@proveca.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|